Quick Answer
SINOVAC BIOTECH LTD reported Stockholders Equity of $8.71 billion for fiscal year 2023.
SINOVAC BIOTECH LTD Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2023 | $8.71B | -2.4% |
| 2022 | $8.92B | -4.4% |
| 2021 | $9.33B | +1149.5% |
| 2020 | $746.47M | +153.9% |
| 2019 | $294.02M | +16.0% |
| 2018 | $253.43M | +67.7% |
| 2017 | $151.15M | +30.6% |
| 2016 | $115.77M | -4.8% |
| 2015 | $121.65M | -3.9% |
| 2014 | $126.56M | -1.6% |
| 2013 | $128.68M | +9.3% |
| 2012 | $117.72M | -9.4% |
| 2011 | $129.92M | +2.8% |
| 2010 | $126.44M | +49.7% |
| 2009 | $84.47M | +48.4% |
| 2008 | $56.90M | — |
- SINOVAC BIOTECH LTD showed a decrease of -2.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2023 period, SINOVAC BIOTECH LTD’s stockholders equity has grown by 15206.8% (from $56.90 million to $8.71 billion).
- The most recent figure is from SINOVAC BIOTECH LTD’s fiscal year 2023 report (Form 20-F), filed with the SEC on April 29, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: